Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
FMC Corp ha un obiettivo di prezzo di consenso pari a $58.85, stabilito in base alle ultime valutazioni degli analisti di 22. Le ultime 3 valutazioni degli analisti sono state rilasciate da Barclays, RBC Capital y Morgan Stanley il agosto 13, 2025, agosto 1, 2025 y agosto 1, 2025. Con un obiettivo di prezzo medio di $44 tra le Barclays, RBC Capital y Morgan Stanley, c'è un implicito 12.53% upside per FMC Corp da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
08/13/2025 | 22.76% | Barclays | $49 → $48 | Maintains | Overweight | |||
08/01/2025 | 7.42% | RBC Capital | $47 → $42 | Maintains | Sector Perform | |||
08/01/2025 | 7.42% | Morgan Stanley | $46 → $42 | Maintains | Equal-Weight | |||
07/31/2025 | 12.53% | UBS | $45 → $44 | Maintains | Neutral | |||
07/14/2025 | 56.01% | Keybanc | $53 → $61 | Maintains | Overweight | |||
07/10/2025 | 20.2% | RBC Capital | $40 → $47 | Maintains | Sector Perform | |||
07/09/2025 | 15.09% | UBS | $41 → $45 | Maintains | Neutral | |||
07/07/2025 | 25.32% | Barclays | $48 → $49 | Maintains | Overweight | |||
06/23/2025 | 27.88% | Wells Fargo | $41 → $50 | Upgrade | Equal-Weight → Overweight | |||
05/02/2025 | 35.55% | Keybanc | $49 → $53 | Maintains | Overweight | |||
05/01/2025 | 4.86% | UBS | $38 → $41 | Maintains | Neutral | |||
04/21/2025 | 4.86% | Wells Fargo | $43 → $41 | Maintains | Equal-Weight | |||
04/14/2025 | 25.32% | Keybanc | $51 → $49 | Maintains | Overweight | |||
03/13/2025 | 30.43% | Goldman Sachs | → $51 | Initiates | → Buy | |||
03/05/2025 | 40.66% | Seaport Global | $72 → $55 | Maintains | Buy | |||
02/18/2025 | 30.43% | Keybanc | $55 → $51 | Maintains | Overweight | |||
02/07/2025 | 22.76% | Barclays | $65 → $48 | Maintains | Overweight | |||
02/07/2025 | -2.81% | UBS | $66 → $38 | Downgrade | Buy → Neutral | |||
02/05/2025 | 22.76% | B of A Securities | $61 → $48 | Downgrade | Neutral → Underperform | |||
02/05/2025 | 27.88% | BMO Capital | $62 → $50 | Maintains | Market Perform | |||
02/05/2025 | 17.65% | Morgan Stanley | $70 → $46 | Maintains | Equal-Weight | |||
02/05/2025 | 20.2% | RBC Capital | $78 → $47 | Downgrade | Outperform → Sector Perform | |||
01/29/2025 | 56.01% | Citigroup | $55 → $61 | Maintains | Neutral | |||
01/28/2025 | 99.49% | RBC Capital | $81 → $78 | Maintains | Outperform | |||
01/21/2025 | 58.57% | BMO Capital | $65 → $62 | Maintains | Market Perform | |||
01/21/2025 | 66.24% | Barclays | $65 → $65 | Upgrade | Equal-Weight → Overweight | |||
01/14/2025 | 56.01% | B of A Securities | $63 → $61 | Upgrade | Underperform → Neutral | |||
01/07/2025 | 40.66% | Mizuho | $70 → $55 | Maintains | Neutral | |||
01/02/2025 | 76.47% | Keybanc | $79 → $69 | Maintains | Overweight | |||
12/20/2024 | 68.8% | UBS | $75 → $66 | Maintains | Buy | |||
12/18/2024 | 40.66% | Citigroup | $70 → $55 | Maintains | Neutral | |||
11/01/2024 | 79.03% | Mizuho | $64 → $70 | Maintains | Neutral | |||
11/01/2024 | 107.16% | RBC Capital | $78 → $81 | Maintains | Outperform | |||
10/23/2024 | 71.36% | Citigroup | → $67 | Initiates | → Neutral | |||
08/12/2024 | 50.9% | JP Morgan | $50 → $59 | Maintains | Neutral | |||
08/05/2024 | 66.24% | Barclays | $62 → $65 | Maintains | Equal-Weight | |||
08/02/2024 | 66.24% | BMO Capital | $60 → $65 | Maintains | Market Perform | |||
08/02/2024 | 102.05% | Keybanc | $81 → $79 | Maintains | Overweight | |||
07/16/2024 | 58.57% | Wells Fargo | $68 → $62 | Maintains | Equal-Weight | |||
06/26/2024 | 58.57% | Barclays | → $62 | Initiates | → Equal-Weight | |||
06/25/2024 | 84.14% | RBC Capital | $81 → $72 | Maintains | Outperform | |||
05/13/2024 | 27.88% | JP Morgan | $53 → $50 | Maintains | Neutral | |||
05/10/2024 | 107.16% | RBC Capital | $65 → $81 | Maintains | Outperform | |||
05/08/2024 | 107.16% | Keybanc | $79 → $81 | Maintains | Overweight | |||
05/08/2024 | 73.91% | Wells Fargo | $65 → $68 | Maintains | Equal-Weight | |||
05/07/2024 | 45.78% | Mizuho | $55 → $57 | Maintains | Neutral | |||
04/09/2024 | 102.05% | Keybanc | $76 → $79 | Maintains | Overweight | |||
03/20/2024 | 114.83% | UBS | $61 → $84 | Upgrade | Neutral → Buy | |||
03/19/2024 | 66.24% | Loop Capital | $55 → $65 | Maintains | Hold | |||
03/01/2024 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
02/12/2024 | 40.66% | Loop Capital | $68 → $55 | Downgrade | Buy → Hold | |||
02/08/2024 | 50.9% | RBC Capital | $61 → $59 | Maintains | Outperform | |||
02/07/2024 | 56.01% | BMO Capital | $63 → $61 | Maintains | Market Perform | |||
02/07/2024 | 43.22% | Exane BNP Paribas | → $56 | Downgrade | Outperform → Neutral | |||
02/07/2024 | 94.37% | Keybanc | $80 → $76 | Maintains | Overweight | |||
02/06/2024 | 40.66% | Mizuho | $59 → $55 | Maintains | Neutral | |||
01/16/2024 | 45.78% | B of A Securities | $60 → $57 | Downgrade | Neutral → Underperform | |||
01/11/2024 | 56.01% | UBS | $59 → $61 | Maintains | Neutral | |||
01/09/2024 | 104.6% | Keybanc | $83 → $80 | Maintains | Overweight | |||
01/04/2024 | 89.26% | Roth MKM | → $74 | Initiates | → Buy | |||
12/14/2023 | 61.13% | BMO Capital | $80 → $63 | Downgrade | Outperform → Market Perform | |||
12/07/2023 | — | Mizuho | — | Downgrade | Buy → Neutral | |||
11/17/2023 | 56.01% | RBC Capital | → $61 | Reiterates | Outperform → Outperform | |||
11/17/2023 | 50.9% | UBS | $64 → $59 | Maintains | Neutral | |||
11/02/2023 | 56.01% | RBC Capital | $80 → $61 | Maintains | Outperform | |||
11/01/2023 | 35.55% | JP Morgan | $90 → $53 | Maintains | Neutral | |||
10/24/2023 | 104.6% | RBC Capital | $105 → $80 | Maintains | Outperform | |||
10/24/2023 | 104.6% | BMO Capital | $90 → $80 | Maintains | Outperform | |||
10/24/2023 | 58.57% | Fermium Research | $85 → $62 | Maintains | Hold | |||
10/24/2023 | 79.03% | Morgan Stanley | $100 → $70 | Downgrade | Overweight → Equal-Weight | |||
10/24/2023 | 112.28% | Keybanc | $107 → $83 | Maintains | Overweight | |||
10/24/2023 | 50.9% | Goldman Sachs | $135 → $59 | Downgrade | Buy → Neutral | |||
10/24/2023 | 61.13% | B of A Securities | → $63 | Downgrade | Buy → Neutral | |||
10/23/2023 | 86.7% | Wells Fargo | $99 → $73 | Maintains | Equal-Weight | |||
10/16/2023 | 140.41% | Vertical Research | → $94 | Upgrade | Hold → Buy | |||
10/10/2023 | 150.64% | Mizuho | $122 → $98 | Maintains | Buy | |||
10/03/2023 | 173.66% | Keybanc | $117 → $107 | Maintains | Overweight | |||
09/25/2023 | 168.54% | RBC Capital | → $105 | Reiterates | Outperform → Outperform | |||
09/25/2023 | — | Redburn Atlantic | — | Downgrade | Buy → Neutral | |||
09/11/2023 | 155.75% | Morgan Stanley | $110 → $100 | Maintains | Overweight | |||
09/05/2023 | 148.08% | UBS | $120 → $97 | Downgrade | Buy → Neutral | |||
08/21/2023 | 130.18% | JP Morgan | → $90 | Initiates | → Neutral | |||
08/04/2023 | 212.02% | Mizuho | $127 → $122 | Maintains | Buy | |||
08/04/2023 | 199.23% | Keybanc | $128 → $117 | Maintains | Overweight | |||
08/04/2023 | 158.31% | Credit Suisse | → $101 | Upgrade | Underperform → Neutral | |||
07/24/2023 | 160.87% | Wells Fargo | $142 → $102 | Downgrade | Overweight → Equal-Weight | |||
07/12/2023 | 212.02% | B of A Securities | $139 → $122 | Maintains | Buy | |||
07/12/2023 | 181.33% | Morgan Stanley | $145 → $110 | Maintains | Overweight | |||
07/11/2023 | 201.79% | Loop Capital | $148 → $118 | Maintains | Buy | |||
07/11/2023 | 181.33% | Morgan Stanley | $145 → $110 | Maintains | Overweight | |||
07/11/2023 | 168.54% | RBC Capital | $136 → $105 | Maintains | Outperform | |||
07/11/2023 | 158.31% | Credit Suisse | $120 → $101 | Maintains | Underperform | |||
07/11/2023 | 206.91% | BMO Capital | $145 → $120 | Maintains | Outperform | |||
07/11/2023 | 224.81% | Mizuho | $147 → $127 | Maintains | Buy | |||
07/11/2023 | 227.37% | Keybanc | $144 → $128 | Maintains | Overweight | |||
07/10/2023 | 168.54% | Fermium Research | $125 → $105 | Maintains | Hold | |||
07/07/2023 | 270.84% | Morgan Stanley | $145 → $145 | Reiterates | Overweight → Overweight | |||
05/04/2023 | 247.83% | RBC Capital | $140 → $136 | Maintains | Outperform | |||
05/03/2023 | 263.17% | Wells Fargo | $148 → $142 | Maintains | Overweight | |||
05/03/2023 | 275.96% | Mizuho | $150 → $147 | Maintains | Buy |
El último precio objetivo de FMC (NYSE:FMC) fue comunicado por Barclays el agosto 13, 2025. La firma de analistas fijó un precio objetivo para $48.00 que espera FMC a rise dentro de 12 meses (un posible 22.76% upside). 34 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para FMC (NYSE:FMC) fue proporcionada por Barclays, y FMC mantuvo su overweight calificación.
La última revisión al alza de FMC Corp se produjo en junio 23, 2025, cuando Wells Fargo elevó su precio objetivo a $50. Wells Fargo anteriormente tenía an equal-weight para FMC Corp.
La última revisión a la baja de FMC Corp se produjo en febrero 7, 2025, cuando UBS cambió su precio objetivo de $66 a $38 para FMC Corp.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de FMC, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de FMC se registró el agosto 13, 2025, por lo que la próxima calificación estará disponible en torno al agosto 13, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de FMC (FMC) fue un mantuvo con un precio objetivo de $49.00 a $48.00. El precio actual al que cotiza FMC (FMC) es de $39.10, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.